Marja Heiskala

1.6k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Marja Heiskala is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Marja Heiskala has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Marja Heiskala's work include Immune Cell Function and Interaction (8 papers), Polyamine Metabolism and Applications (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Marja Heiskala is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Polyamine Metabolism and Applications (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Marja Heiskala collaborates with scholars based in Finland, United States and Sweden. Marja Heiskala's co-authors include Per A. Peterson, Pauline T. Lieu, Young Mok Yang, Young Chul Yang, Leif C. Andersson, Kaarle Franssila, Tuomo Timonen, Hannu Heiskala, Anna Pelander and Päivi Heikkilä and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Marja Heiskala

25 papers receiving 1.2k citations

Hit Papers

The roles of iron in health and disease 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The roles of iron in health and disease
    2001 610 citations Pauline T. Lieu, Marja Heiskala et al. Molecular Aspects of Medicine profile →

Peers

Marja Heiskala
Louise Dunn Australia
Elena Gammella Italy
J F Kolhouse United States
David A. Slatter United Kingdom
Marina Bayeva United States
Liyun Chen China
Yoshiro Kobayashi Japan
Yan Jiao United States
Mingwei Qian United States
Ming Gao China
Louise Dunn Australia
Marja Heiskala
Citations per year, relative to Marja Heiskala Marja Heiskala (= 1×) peers Louise Dunn

Countries citing papers authored by Marja Heiskala

Since Specialization
Citations

This map shows the geographic impact of Marja Heiskala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja Heiskala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja Heiskala more than expected).

Fields of papers citing papers by Marja Heiskala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marja Heiskala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja Heiskala. The network helps show where Marja Heiskala may publish in the future.

Co-authorship network of co-authors of Marja Heiskala

This figure shows the co-authorship network connecting the top 25 collaborators of Marja Heiskala. A scholar is included among the top collaborators of Marja Heiskala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marja Heiskala. Marja Heiskala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joensuu, Kristiina, et al.. (2023). Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(2). 215–224. 1 indexed citations
2.
Heiskala, Marja, Kristiina Joensuu, & Päivi Heikkilä. (2021). Core Needle Biopsy Enhances the Activity of the CCL2/CCR2 Pathway in the Microenvironment of Invasive Breast Cancer. MDPI (MDPI AG). 2(1). 1–18. 1 indexed citations
3.
Heiskala, Marja, Marjut Leidenius, Kristiina Joensuu, & Päivi Heikkilä. (2018). High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 474(1). 3–12. 40 indexed citations
4.
Chan, Emily, Eunice L. Kwak, Jimmy Hwang, et al.. (2015). Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease. Cancer Chemotherapy and Pharmacology. 75(4). 701–709. 17 indexed citations
5.
Arola, Johanna, et al.. (2010). Expression of Reg IV and Hath1 in neuroendocrine neoplasms.. PubMed. 25(1). 63–72. 22 indexed citations
6.
Kanerva, Kristiina, et al.. (2007). Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase. Biochemical Journal. 409(1). 187–192. 53 indexed citations
7.
Giles‐Komar, Jill, et al.. (2005). High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(3). 295–300. 19 indexed citations
8.
Sun, Li, et al.. (2004). Impact of Fixative on Recovery of mRNA From Paraffin-Embedded Tissue. Diagnostic Molecular Pathology. 13(2). 116–125. 50 indexed citations
9.
Kämäräinen, Meerit, et al.. (2003). RELP, a Novel Human Reg-Like Protein with Up-Regulated Expression in Inflammatory and Metaplastic Gastrointestinal Mucosa. American Journal Of Pathology. 163(1). 11–20. 40 indexed citations
10.
Lieu, Pauline T., Marja Heiskala, Per A. Peterson, & Young Mok Yang. (2001). The roles of iron in health and disease. Molecular Aspects of Medicine. 22(1-2). 1–87. 610 indexed citations breakdown →
11.
Heiskala, Marja, Per A. Peterson, & Young Chul Yang. (2001). The Roles of Claudin Superfamily Proteins in Paracellular Transport. Traffic. 2(2). 92–98. 208 indexed citations
12.
Heiskala, Marja, et al.. (2001). Expression of a Novel Human Ornithine Decarboxylase-like Protein in the Central Nervous System and Testes. Biochemical and Biophysical Research Communications. 287(5). 1051–1057. 56 indexed citations
13.
Heiskala, Marja. (1999). Translocation of ornithine decarboxylase to the surface membrane during cell activation and transformation. The EMBO Journal. 18(5). 1214–1222. 30 indexed citations
14.
Ståhls, Anders, Marja Heiskala, Tomas Mustelin, & Leif C. Andersson. (1992). Activation of natural killer cells via the FcγRIII (CD16) requires initial tyrosine phosphorylation. European Journal of Immunology. 22(2). 611–614. 15 indexed citations
15.
Heiskala, Marja, Anders Ståhls, Ilkka Seppälä, & Tuomo Timonen. (1991). Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.. PubMed. 10(5). 265–77. 1 indexed citations
16.
Heiskala, Marja, Manuel E. Patarroyo, & Tuomo Timonen. (1990). Participation of CD11a–c/CD18 and RGD‐Recognizing Adhesion Molecules in the Binding of LGL to Fibroblasts. Scandinavian Journal of Immunology. 32(2). 137–147. 5 indexed citations
17.
Heiskala, Marja, Ulf‐Håkan Stenman, Erkki Koivunen, et al.. (1988). Characteristics of Soluble Tumour‐Derived Proteins That Inhibit Natural Killer Activity. Scandinavian Journal of Immunology. 28(1). 19–27. 12 indexed citations
18.
Franssila, Kaarle, Marja Heiskala, & Juhani Rapola. (1987). Non-Hodgkin's lymphomas in childhood a clinicopathologic and epidemiologic study in finland. Cancer. 59(10). 1837–1846. 12 indexed citations
19.
Heiskala, Marja & Tuomo Timonen. (1987). Effect of interleukin 2 on the inhibition of human natural killer activity by monolayer cells. Cellular Immunology. 110(2). 209–217. 11 indexed citations
20.
Heiskala, Marja, Olavi Ylikorkala, & Tuomo Timonen. (1987). Inhibition of human natural killer activity by monolayers of primary cell cultures.. PubMed. 6(1). 1–11. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise Dunn Breakdown of academic impact, for papers by Elena Gammella Breakdown of academic impact, for papers by J F Kolhouse Breakdown of academic impact, for papers by David A. Slatter Breakdown of academic impact, for papers by Marina Bayeva Breakdown of academic impact, for papers by Liyun Chen Breakdown of academic impact, for papers by Yoshiro Kobayashi Breakdown of academic impact, for papers by Yan Jiao Breakdown of academic impact, for papers by Mingwei Qian Breakdown of academic impact, for papers by Ming Gao
Rankless by CCL
2026